ROSSARI
Rossari Biotech
Each stock's 10,000-path forecast, rendered as light.
Rossari Biotech (ROSSARI) Stock Analysis & Case Study
Is ROSSARI a good buy? The data-driven verdict.
on the numbers it tread carefully, a Downstox Snapshot Score of 44/100.
On the numbers, Rossari Biotech (ROSSARI) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 23% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
ROSSARI share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of ROSSARI history (-19%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ROSSARI 2027 | ₹291 | ₹438 | ₹670 | -22% |
| ROSSARI 2028 | ₹191 | ₹345 | ₹625 | -38% |
| ROSSARI 2029 | ₹133 | ₹271 | ₹557 | -52% |
| ROSSARI 2030 | ₹92 | ₹213 | ₹488 | -62% |
| ROSSARI 2031 | ₹66 | ₹166 | ₹428 | -70% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ROSSARI goes up, or doubles?
The bull case for ROSSARI
- Rossari Biotech is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹557.
The bear case & risks
- The probability model is cautious 12 months out, only a 23% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹133.
ROSSARI volatility & expected range, how bumpy is the ride?
Over the last 2.0 years ROSSARI compounded at -19%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹291–₹670, the honest backbone behind any single price target.
ROSSARI price forecast, the full 60-month probability fan
ROSSARI price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ROSSARI hits common targets within the simulated horizon?
Full multi-horizon detail on the ROSSARI price target & forecast page.
ROSSARI MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy ROSSARI with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 31.9% | 3.1× |
| Dhan | 40.0% | 2.5× |
Compare every broker on the ROSSARI MTF page.
ROSSARI vs peers,sector comparison
About Rossari Biotech: sector, index & market-cap context
Rossari Biotech (ROSSARI) is an NSE-listed company.
How the ROSSARI Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Rossari Biotech's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ROSSARI analysis, FAQs
Is Rossari Biotech (ROSSARI) a good buy?
On the numbers, Rossari Biotech (ROSSARI) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 23% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ROSSARI overvalued or undervalued?
Valuation ratios for ROSSARI are tracked live on Downstox.
What is the ROSSARI share price target for 2031?
ROSSARI's probability-weighted 2031 median target is ₹166, with an 80% range of ₹66–₹428 (10,000-path Monte-Carlo).
What is the probability ROSSARI doubles in 5 years?
The modelled probability of ROSSARI reaching ₹1,122 (2×) within 5 years is 0%.
What is the bull case for ROSSARI?
Rossari Biotech is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in ROSSARI?
The probability model is cautious 12 months out, only a 23% chance of finishing above today's price.